Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 26, Number 8—August 2020
Letter

Infections among Contacts of Patients with Nipah Virus, India

On This Page
Article Metrics

Cite This Article

To the Editor: Kumar et al. recently reported 3 asymptomatic, seropositive persons with Nipah virus (NiV) among 279 contacts of 18 NiV-infected patients (1). In the 1998–1999 NiV outbreak in Malaysia, asymptomatic, seropositive persons, most of whom were farm workers and soldiers involved in pig culling, also were identified (2,3). Furthermore, some additional cases might not have been detected among patients who had mild, nonencephalitic symptoms (e.g., fever, influenza-like illness). Up to 16% of asymptomatic, seropositive persons exhibited lesions in their brain magnetic resonance imaging (MRI) scans, albeit a slightly smaller number than in patients with acute NiV encephalitis (2). These discrete, small high-signal lesions in the cerebrum were best seen on fluid-attenuated inversion recovery images (2). In another study, a seropositive nurse who was exposed only to patients also had similar brain lesions visible on an MRI scan, suggesting person-to-person transmission (4). Whether late-onset NiV encephalitis (i.e., encephalitis in an asymptomatic or mildly symptomatic person) would develop in any of these persons, especially those with brain lesions visible on MRI scan, is unknown. In another cohort, approximately 5% of asymptomatic or mildly symptomatic persons (5) had febrile encephalitis characterized by headache, seizures, focal neurologic signs, and cerebrospinal fluid pleocytosis, a set of symptoms and signs distinct from acute NiV encephalitis. In patients who survived acute NiV encephalitis, a clinicopathologically similar relapsing encephalitis has also been reported (5). The death rate was ≈20% during the clinical course of late-onset/relapsing NiV encephalitis (5).

Physicians should consider using brain MRI to identify subclinical brain lesions in asymptomatic, seropositive Nipah patients. Moreover, physicians should advise patients of the possibility that late-onset encephalitis might occur months or even years after virus exposure (5). New treatments are in development or on trial, so patients with these complications may be offered access to effective treatments.

Top

Chong Tin Tan and Kum Thong WongComments to Author 

Author affiliations: University of Malaya, Kuala Lumpur, Malaysia

Top

References

  1. Kumar  CPG, Sugunan  AP, Yadav  P, Kurup  KK, Aarathee  R, Manickam  P, et al. Infections among contacts of patients with Nipah virus, India. Emerg Infect Dis. 2019;25:100710. DOIPubMed
  2. Kumar  CPG, Sugunan  AP, Yadav  P, Kurup  KK, Aarathee  R, Manickam  P, et al. Infections among contacts of patients with Nipah virus, India. Emerg Infect Dis. 2019;25:100710. DOIPubMed
  3. Tan  KS, Ahmad Sarji  S, Tan  CT, Abdullah  BJ, Chong  HT, Thayapran  T, et al. Patients with asymptomatic Nipah virus infection may have abnormal cerebral MR imaging. Neurology Journal of Southeast Asia. 2000;5:6973.
  4. Ali  R, Mounts  AW, Parashar  UD, Sahani  M, Lye  MS, Isa  MM, et al. Nipah virus among military personnel involved in pig culling during an outbreak of encephalitis in Malaysia, 1998-1999. Emerg Infect Dis. 2001;7:75961. DOIPubMed
  5. Tan  CT, Tan  KS. Nosocomial transmissibility of Nipah virus. J Infect Dis. 2001;184:1367. DOIPubMed
  6. Chong  HT, Tan  CT. Relapsed and late-onset Nipah encephalitis, a report of 3 cases. Neurology Journal of Southeast Asia. 2003;8:10912.

Top

Cite This Article

DOI: 10.3201/eid2608.190722

Original Publication Date: June 29, 2020

Related Links

Top

Table of Contents – Volume 26, Number 8—August 2020

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Kum Thong Wong, Department of Pathology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia

Send To

character(s) remaining.

Comment submitted successfully, thank you for your feedback.

Top

Page created: April 27, 2020
Page updated: July 18, 2020
Page reviewed: July 18, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external